Original Article

Expression Level of Circulating miR-93 in Serum of Patients with Diabetic Nephropathy

Volume 22 · Issue 2 Publish Date: June 1, 2018
Full Text PDF
DOI
Masoume AKHBARI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Maryam SHAHRABI -FARAHANI
Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
Alireza BIGLARI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Mitra KHALILI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Fatemeh BANDARIAN
Tehran University of Medical Sciences, Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
AKHBARI, M., SHAHRABI -FARAHANI, M., BIGLARI, A., KHALILI, M., & BANDARIAN, F. (2018). Expression Level of Circulating miR-93 in Serum of Patients with Diabetic Nephropathy. Endocrinology Research and Practice, 22(2), 78–84. https://doi.org/10.25179/tjem.2018-59661
Full Text Full Text PDF

Abstract

ABSTRACT

Objective: Diabetic nephropathy is a long-term complication of diabetes and is manifested as reduced glomerular filtration rate, increased urinary albumin excretion, and glomerular lesions. The study aim was to determine the expression level of serum cell-free mir-93 in diabetic patients with or without DN and compare that to healthy controls.

Material and Methods: In this case-control study, 61 type 2 diabetes patients (21 without diabetic nephropathy, 20 with microalbuminuria and 20 with macroalbuminuria), and 22 healthy controls were included. Cell-free microRNA was extracted from the serum of participants and real-time polymerase chain reaction was performed using SYBR Green master mix. The gene of hsa-miR-16 was used as a reference gene.

Results: Our findings revealed a significant downregulation of miR-93 expression in the serum of diabetic patients with or without nephropathy compared to the healthy individuals (p<0.005). However, there was no significant difference between the three groups of diabetic patients presenting different degrees of nephropathy.

Conclusion: Serum miR-93 is a good diagnostic marker for diabetes, but is not useful to distinguish between the diabetics with and without nephropathy.

Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 22 · Issue 2
Pages 78-84
History
Published Online June 1, 2018
Copyright
Affiliations
Masoume AKHBARI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Maryam SHAHRABI -FARAHANI
Tehran University of Medical Sciences, Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
Alireza BIGLARI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Mitra KHALILI
Zanjan University of Medical Sciences, Department of Medical Genetics and Molecular Medicine, Zanjan, Iran
Fatemeh BANDARIAN
Tehran University of Medical Sciences, Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran, Iran
Cite this Article
AKHBARI, M., SHAHRABI -FARAHANI, M., BIGLARI, A., KHALILI, M., & BANDARIAN, F. (2018). Expression Level of Circulating miR-93 in Serum of Patients with Diabetic Nephropathy. Endocrinology Research and Practice, 22(2), 78–84. https://doi.org/10.25179/tjem.2018-59661
Outlines